Cambridge Journals Online

Erik Hessen, Morten I. Lossius, Ivar Reinvang and Leif Gjerstad (). Improvement in Speeded Cognitive Processing After Anti-epileptic Drug Withdrawal – A Controlled Study in Mono-therapy Patients. Progress in Neurotherapeutics and Neuropsychopharmacology, 3 , pp 199-209
doi:10.1017/S1748232107000109

Paulo Caramelli and Luiz Henrique Martins Castro (). Dementia associated with epilepsy. International Psychogeriatrics, 17 , pp S195-S206
doi:10.1017/S1041610205002024

ELISA KANTOLA-SORSA, EIJA GAILY, MIRVA ISOAHO and MARIT KORKMAN (). Neuropsychological outcomes in children of mothers with epilepsy. Journal of the International Neuropsychological Society, 13 , pp 642-652
doi:10.1017/S1355617707070804

P. R. Kritzinger and G. P. Jordaan (). Catatonia: an open prospective series with carbamazepine. The International Journal of Neuropsychopharmacology, 4 , pp 251-257
doi:10.1017/S1461145701002486

Hakuei Yamashita, Tetsushi Kazawa, Yukiko Minatogawa, Takashi Ebisawa and Toshio Yamauchi (). Time-course of hepatic cytochrome P450 subfamily induction by chronic carbamazepine treatment in rats. The International Journal of Neuropsychopharmacology, 5 , pp 47-52
doi:10.1017/S1461145701002747

E. Ephraim and R. Prettyman (). Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs. International Psychogeriatrics, 21 , pp 576-580
doi:10.1017/S1041610209008667

Paolo Brambilla, Francesco Barale and Jair C. Soares (). Perspectives on the use of anticonvulsants in the treatment of bipolar disorder. The International Journal of Neuropsychopharmacology, 4 , pp 421-446
doi:10.1017/S1461145701002668

Robert M. A. Hirschfeld and Siegfried Kasper (). A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. The International Journal of Neuropsychopharmacology, 7 , pp 507-522
doi:10.1017/S1461145704004651